I came to this work through two very different doors.

The first was clinical. Years working in hospital settings showed me firsthand how a disconnected medical system leaves people without answers and sometimes without hope. That gap between what medicine offers and what people actually need troubled me.

The second door was more personal.

I was raised with faith, then spent years rejecting it entirely. Science became my framework, and it felt complete.

But certain experiences kept finding me anyway. Reminding me of what I lived and learned in childhood. And persistently, they pointed back toward something I had forgotten: a sense that we are connected to something larger and that there is a source from which we all come. It was a truth I could no longer argue myself out of.

That's what draws me to psychedelic science. These studies are a bridge between two things I now know to be true: that evidence matters, and that human experience reaches further than our instruments can capture. They showed me that there's a gap between science and spirit, and that's what I'd like to bridge.

Tending
The Future

Stephanie Karzon Abrams neuroscientist, consultant, author, and speaker specializing in psychedelics, women's health, traumatic brain injury, spinal cord injury, and the neuroscience of music and psychedelic-assisted therapy photo emily eizen
Illustration of a hot air balloon with a woodgrain pattern and an eye in the center.

My work lives where structure meets flow—where evidence becomes illumination, and the scaffolding of science gives way to something more fluid, more felt. It builds bridges: between disciplines, between people, between what is known and what is just beginning to be imagined.

Looking back, my years of experience span multiple worlds: the empirical and the intuitive, the measurable and the ineffable. This is the language of thresholds, fluent in both data and metaphor, design and emergence.

From psychedelic therapy models to women’s health and neuroscience, from artistic collaborations to strategic consulting, my mission remains clear: to design futures that hold meaning. Futures that honour where we’ve been and reach tenderly toward what’s possible.

A hot air balloon with a design resembling wood grain and a large eye on its surface, floating in a black background.

I believe in the wisdom of the body. The poetry of small moments. The alchemy of movement, memory, and sound.

And I believe that life doesn’t ask us to choose between intellect and intuition, but to find rhythm in the dance between them.

Cultural
Architecture

Stephanie Karzon Abrams neuroscientist, consultant, author, and speaker specializing in psychedelics, women's health, traumatic brain injury, spinal cord injury, and the neuroscience of music and psychedelic-assisted therapy photo emily eizen

Living systems crave coherence. Ideas shape behavior and language builds reality.
Culture is a living organism, continually evolving, shaped not only by what we do but by what we dare to imagine.

Over time, my work has alchemized itself with passion, no longer a separate pursuit, but a lived expression. What once felt compartmentalized now moves as one: curiosity, creation, contribution.

This work has invited me to design with intention.
To both question and revere what’s been inherited.
To hold complexity with care. And to create the conditions for a more regenerative future, built on innovation and integrity.

The world needs more resonance.
More curiosity.
More coherence.
More brave visions spoken
into form.

Stephanie Karzon Abrams neuroscientist, consultant, author, and speaker specializing in psychedelics, women's health, traumatic brain injury, spinal cord injury, and the neuroscience of music and psychedelic-assisted therapy photo emily eizen

Curriculum Vitae

  • Post Graduate and Continuing Medical Education
    i. Certificate of Continuing Medical Education, Psychedelic Medicine Association-Managing Medical Risk in Patients Seeking Psilocybin Therapy

    ii. Certificate of Continuing Medical Education, Therapsil-Psilocybin Prescriber

    iii. Certificate of Continuing Medical Education, Numinus-Molecular Foundations: Psilocybin-Molecular Foundations: MDMA-Molecular Foundations: Ketamine

    iv. Certificate of Continuing Medical Education, Therapsil Prescriber for Psilocybin Therapy, Canada

    Masters of Science Clinical Pharmacology, Faculty of Medicine, University of Montreal
    i. Specializations: neurology, neuro/psychopharmacology
    ii. Research Fellowship: Intensive Care and Traumatic Brain Injury

    Bachelors of Science Biopharmaceutical Sciences, Faculty of Pharmacy, University of Montreal

    Neuropsychology and Linguistics, Faculty of Arts and Science, University of Montreal

    Minor Linguistics, University of Montreal

  • Founder, Beyond Consulting, 2022-present

    Clinical Director, Mystic Health, 2025-present

    Clinical Director, Modern Medicine Services, 2023-2025

    Researcher, North Toronto Neurology, 2024- present

    MDMA & Psilocybin Therapy Associate Prescriber (independant), Therapsil Canada, 2023-present

    Research Director, Microdosing Collective 501c3, 2023-present

    Writer/Speaker, Freelance, 2023- present

    Researcher, Neurology Centre of TO, Numinus 2022- 2024

    Therapy Awareness & Market Dev. Advisor, Biosense Webster, Johnson & Johnson - 2018-2022

    Field Trainer & Educator, Biosense Webster, Johnson & Johnson - 2018-2022

    Sr. Clinical Specialist, Biosense Webster, Johnson & Johnson, 2016-2022

    Researcher & Clinical Study Coordinator, Intensive Care & Internal Medicine, Hôpital du Sacré-Coeur de Mtl, 2015-2017

  • TedX Speaker, 2024
    Psychedelics and Ancient Wisdom for Modern Healing

    Inner State Advisor, Share holder, 2025-
    A pre-clinical biotech company specializing in psychedelic producing fungi for drug discovery focused on enhancing women’s health and well-being.

    People Science, Advisor, Share holder, 2025-
    Technology enabled clinical research company addressing the need for affordable rigorous clinical science.

    Fungi Forward, Advisor, Share holder, 2025-
    Creating novel, data backed & side effect free therapeutics for the treatment of epilepsy and beyond.

    Psychedelic Medicine Association, Member, 2023-
    Society of physicians, therapists, and industry leaders looking to foster the therapeutic use of psychedelics.

    Therapsil, Non-profit, Member, 2023-
    TheraPsil is a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy and medical psilocybin.

    American Society for Pharmacology and Experimental Therapies, Member, 2022
    Society founded by John Jacob Abel of John Hopkins University to promote growth of pharmacological research.

    Microdosing Collective, 501.c3, 2023 Research Director
    Initiative to promote harm reduction and access to low dose psychedelics.

    Psychedelics & Pain Association, Member, 2024-
    PPA advances science and public awareness towards a future where psychedelic medicines will significantly reduce chronic pain and suffering.

    Kawasaki Disease Foundation, 501c3, Board Member, 2021
    Foundation supporting research and awareness for Kawasaki Disease as well as supporting individuals and families affected by KD.

    1. Persons with Spinal Cord Injury report peripherally dominant serotonin-like syndrome after use of serotonergic psychedelics, Karzon, S*†., Rabinovitch, B*†., Zafar, R., Aziz, A., Nielson, J.L‡, Lewis, EC†§ . Neurotrauma Reports. June 2023. NEUR-2023-0022.R1.

    2. Cognitive and motor function effects of antipsychotics in traumatic brain injury: a systematic review of preclinical studies, Gabrielle Cataford, Pharm.D, Laurie-Anne Monton, Pharm.D, Stephanie Karzon, B.Sc., M.Sc., D. Williamson, et al. Neurotrauma Reports. March 2024. NEUR-2023.0108

    3. A systematic review of interventions to facilitate extubation in patients difficult-to-wean due to delirium, agitation, or anxiety and a meta-analysis of the effect of dexmedetomidine, Sébastien Dupuis PharmD, MSc, Dave Brindamour BPharm, MSc, Stephanie Karzon BSc, MSc, Anne Julie Frenette BPharm, MSc, Emmanuel Charbonney MD, PhD, Marc M. Perreault PharmD, MSc, Patrick Bellemare MD, Lisa Burry PharmD & David R. Williamson BPharm, MSc, PhD, 9 Jan 23. PMID: 30674004.

  • https://www.stephaniekarzonabrams.com/press

Research & Interests

  • -Traumatic brain injury

    -Spinal cord injury

    -Headache

    -Chronic pain

    -Women’s health

    -Hormonal and sexual health

    -Music & Neuroscience

    • Altered states and

      -Physical therapy and rehabilitation

      -Athletic performance and help achieve flow state

    • Relationships, connection to self and to others

    • Women’s hormone health

    • The history of plant medicines within my own ancestral culture.

    • Stacking functional and medicinal plants

    • Optimizing the therapeutic experience for patients

    • Advocating for the betterment of patient care through educating and public speaking

    • Can altered states and mystical experiences make us better humans?

    • Dreams and the subconscious

    • Music
      -As a language
      -As a psychedelic
      -Neuroscience
      -Dance/Rave culture

    • Joy

    • Science Communication

    • Creative & Stream of Consciousness

    • Thought Pieces

    • Music

    • Rave Culture

    • Women

    • Love

    • Poetry

Stephanie Karzon Abrams neuroscientist, consultant, author, and speaker specializing in psychedelics, women's health, traumatic brain injury, spinal cord injury, and the neuroscience of music and psychedelic-assisted therapy photo emily eizen